Literature DB >> 15936659

The HIV coreceptor switch: a population dynamical perspective.

Roland R Regoes1, Sebastian Bonhoeffer.   

Abstract

Over the course of infection, the coreceptor usage of the HIV virus changes from a preference for CCR5 to a preference for CXCR4 in approximately 50% of infected individuals. The change in coreceptor usage is the result of the complex interaction of the viral population with various cell populations of the immune system. Although many of the molecular processes involved in viral attachment and entry have been resolved, the population dynamical mechanisms leading to the emergence of CXCR4-using HIV variants in some infected individuals are not yet understood. Here, we review various hypotheses that have been proposed to explain the change of HIV coreceptor usage in the course of infection, and conclude that any corroboration or rejection of these hypotheses requires a quantitative analysis of the interaction between the virus and immune cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936659     DOI: 10.1016/j.tim.2005.04.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  79 in total

1.  Persistence and emergence of X4 virus in HIV infection.

Authors:  Ariel D Weinberger; Alan S Perelson
Journal:  Math Biosci Eng       Date:  2011-04       Impact factor: 2.080

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.

Authors:  Ujjwal Neogi; Sreenivasa B Prarthana; George D'Souza; Ayesha Decosta; Vijesh S Kuttiatt; Udaykumar Ranga; Anita Shet
Journal:  AIDS Res Ther       Date:  2010-07-21       Impact factor: 2.250

4.  Correlation of partial env gene sequences with disease progression parameters in HIV-positive pregnant women from India.

Authors:  Supriya Singh; Shashi Khare; Sudha Prasad; R L Ichhpujani; S S Negi; Sachin Kumar; D S Rawat; L S Chauhan; Arvind Rai
Journal:  Med Microbiol Immunol       Date:  2012-01-25       Impact factor: 3.402

5.  Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652.

Authors:  Masanori Baba; Hiroshi Miyake; Xin Wang; Mika Okamoto; Katsunori Takashima
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

6.  Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.

Authors:  Ruy M Ribeiro; Mette D Hazenberg; Alan S Perelson; Miles P Davenport
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.

Authors:  Mattias Mild; Joakim Esbjörnsson; Eva Maria Fenyö; Patrik Medstrand
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

8.  Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load.

Authors:  Victor G Kramer; Susan M Schader; Maureen Oliveira; Susan P Colby-Germinario; Daniel A Donahue; Diane N Singhroy; Randy Tressler; Richard D Sloan; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

9.  Analysis of Immunological, Viral, Genetic, and Environmental Factors That Might Be Associated with Decreased Susceptibility to HIV Infection in Serodiscordant Couples in Florianópolis, Southern Brazil.

Authors:  Íris M Santos; Elis A da Rosa; Tiago Gräf; Luiz G E Ferreira; Andrea Petry; Fernanda Cavalheiro; Edna M Reiche; Carlos R Zanetti; Aguinaldo R Pinto
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

10.  Different mutational pathways to CXCR4 coreceptor switch of CCR5-using simian-human immunodeficiency virus.

Authors:  Siu-hong Ho; Nataliya Trunova; Agegnehu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.